APO Research
Talk to an analyst

APO RESEARCH · REPORT

Methotrexate Sodium

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Methotrexate Sodium Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchMethotrexate Sodium Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Methotrexate Sodium Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Methotrexate Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Methotrexate Sodium Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Methotrexate Sodium Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Methotrexate Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Methotrexate Sodium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Methotrexate Sodium market include HOSPIRA, Qualitest(DAVA Pharmaceuticals), Roxane Laboratories Inc., STADA Pharmaceuticals, Inc, Teva USA(Barr Laboratories) and Mylan Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Methotrexate Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Methotrexate Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Methotrexate Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Methotrexate Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Methotrexate Sodium Segment by Company

HOSPIRA

Qualitest(DAVA Pharmaceuticals)

Roxane Laboratories Inc.

STADA Pharmaceuticals, Inc

Teva USA(Barr Laboratories)

Mylan Pharmaceuticals Inc.

Methotrexate Sodium Segment by Type

Methotrexate Sodium Tablet

Methotrexate Sodium Solution

Methotrexate Sodium Segment by Application

Oral

Injection

Methotrexate Sodium Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Methotrexate Sodium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Methotrexate Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Methotrexate Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Methotrexate Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Methotrexate Sodium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Methotrexate Sodium industry.

Chapter 3: Detailed analysis of Methotrexate Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Methotrexate Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Methotrexate Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Methotrexate Sodium Industry Trends Table 2. Methotrexate Sodium Industry Drivers Table 3. Methotrexate Sodium Industry Opportunities and Challenges Table 4. Methotrexate Sodium Industry Restraints Table 5. Global Methotrexate Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Methotrexate Sodium Revenue Share by Company (2021-2026) Table 7. Global Methotrexate Sodium Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Methotrexate Sodium Sales Volume Share by Company (2021-2026) Table 9. Global Methotrexate Sodium Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Methotrexate Sodium Company Ranking, (2024-2026) & (USD Million) Table 11. Global Methotrexate Sodium Key Company Manufacturing Base & Headquarters Table 12. Global Methotrexate Sodium Company, Product Type & Application Table 13. Global Methotrexate Sodium Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Methotrexate Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Methotrexate Sodium Tablet Table 18. Significant Companies of Methotrexate Sodium Solution Table 19. Global Methotrexate Sodium Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Methotrexate Sodium Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Methotrexate Sodium Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Methotrexate Sodium Sales Volume Share by Type (2021-2026) Table 23. Global Methotrexate Sodium Sales Volume Share by Type (2027-2032) Table 24. Global Methotrexate Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Methotrexate Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Methotrexate Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Methotrexate Sodium Sales Value Share by Type (2021-2026) Table 28. Global Methotrexate Sodium Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oral Table 30. Significant Companies of Injection Table 31. Global Methotrexate Sodium Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Methotrexate Sodium Sales Volume by Application (2021-2026) & (W Units) Table 33. Global Methotrexate Sodium Sales Volume by Application (2027-2032) & (W Units) Table 34. Global Methotrexate Sodium Sales Volume Share by Application (2021-2026) Table 35. Global Methotrexate Sodium Sales Volume Share by Application (2027-2032) Table 36. Global Methotrexate Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Methotrexate Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Methotrexate Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Methotrexate Sodium Sales Value Share by Application (2021-2026) Table 40. Global Methotrexate Sodium Sales Value Share by Application (2027-2032) Table 41. Global Methotrexate Sodium Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Methotrexate Sodium Sales by Region (2021-2026) & (W Units) Table 43. Global Methotrexate Sodium Sales Market Share by Region (2021-2026) Table 44. Global Methotrexate Sodium Sales by Region (2027-2032) & (W Units) Table 45. Global Methotrexate Sodium Sales Market Share by Region (2027-2032) Table 46. Global Methotrexate Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Methotrexate Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Methotrexate Sodium Sales Value Share by Region (2021-2026) Table 49. Global Methotrexate Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Methotrexate Sodium Sales Value Share by Region (2027-2032) Table 51. Global Methotrexate Sodium Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Methotrexate Sodium Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Methotrexate Sodium Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Global Methotrexate Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Methotrexate Sodium Sales by Country (2021-2026) & (W Units) Table 56. Global Methotrexate Sodium Sales Market Share by Country (2021-2026) Table 57. Global Methotrexate Sodium Sales by Country (2027-2032) & (W Units) Table 58. Global Methotrexate Sodium Sales Market Share by Country (2027-2032) Table 59. Global Methotrexate Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Methotrexate Sodium Sales Value Market Share by Country (2021-2026) Table 61. Global Methotrexate Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Methotrexate Sodium Sales Value Market Share by Country (2027-2032) Table 63. HOSPIRA Company Information Table 64. HOSPIRA Business Overview Table 65. HOSPIRA Methotrexate Sodium Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. HOSPIRA Methotrexate Sodium Product Portfolio Table 67. HOSPIRA Recent Development Table 68. Qualitest(DAVA Pharmaceuticals) Company Information Table 69. Qualitest(DAVA Pharmaceuticals) Business Overview Table 70. Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Product Portfolio Table 72. Qualitest(DAVA Pharmaceuticals) Recent Development Table 73. Roxane Laboratories Inc. Company Information Table 74. Roxane Laboratories Inc. Business Overview Table 75. Roxane Laboratories Inc. Methotrexate Sodium Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Roxane Laboratories Inc. Methotrexate Sodium Product Portfolio Table 77. Roxane Laboratories Inc. Recent Development Table 78. STADA Pharmaceuticals, Inc Company Information Table 79. STADA Pharmaceuticals, Inc Business Overview Table 80. STADA Pharmaceuticals, Inc Methotrexate Sodium Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. STADA Pharmaceuticals, Inc Methotrexate Sodium Product Portfolio Table 82. STADA Pharmaceuticals, Inc Recent Development Table 83. Teva USA(Barr Laboratories) Company Information Table 84. Teva USA(Barr Laboratories) Business Overview Table 85. Teva USA(Barr Laboratories) Methotrexate Sodium Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Teva USA(Barr Laboratories) Methotrexate Sodium Product Portfolio Table 87. Teva USA(Barr Laboratories) Recent Development Table 88. Mylan Pharmaceuticals Inc. Company Information Table 89. Mylan Pharmaceuticals Inc. Business Overview Table 90. Mylan Pharmaceuticals Inc. Methotrexate Sodium Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Pharmaceuticals Inc. Methotrexate Sodium Product Portfolio Table 92. Mylan Pharmaceuticals Inc. Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Methotrexate Sodium Distributors List Table 96. Methotrexate Sodium Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Methotrexate Sodium Product Image Figure 2. Global Methotrexate Sodium Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Methotrexate Sodium Sales Value (2021-2032) & (US$ Million) Figure 4. Global Methotrexate Sodium Sales (2021-2032) & (W Units) Figure 5. Global Methotrexate Sodium Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Methotrexate Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Methotrexate Sodium Tablet Image Figure 10. Methotrexate Sodium Solution Image Figure 11. Global Methotrexate Sodium Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Methotrexate Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Methotrexate Sodium Sales Volume Share by Type (2021-2032) Figure 14. Global Methotrexate Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Methotrexate Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Methotrexate Sodium Sales Value Share by Type (2021-2032) Figure 17. Oral Image Figure 18. Injection Image Figure 19. Global Methotrexate Sodium Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Methotrexate Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Methotrexate Sodium Sales Volume Share by Application (2021-2032) Figure 22. Global Methotrexate Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Methotrexate Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Methotrexate Sodium Sales Value Share by Application (2021-2032) Figure 25. Global Methotrexate Sodium Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 26. Global Methotrexate Sodium Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Methotrexate Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Methotrexate Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Methotrexate Sodium Sales Value (2021-2032) & (US$ Million) Figure 30. North America Methotrexate Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Methotrexate Sodium Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Methotrexate Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Methotrexate Sodium Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Methotrexate Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Methotrexate Sodium Sales Value (2021-2032) & (US$ Million) Figure 36. South America Methotrexate Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Methotrexate Sodium Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Methotrexate Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Methotrexate Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Methotrexate Sodium Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Methotrexate Sodium Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Methotrexate Sodium Tablet
  • Methotrexate Sodium Solution
Applications
  • Oral
  • Injection
Companies covered
  • HOSPIRA
  • Qualitest(DAVA Pharmaceuticals)
  • Roxane Laboratories Inc.
  • STADA Pharmaceuticals, Inc
  • Teva USA(Barr Laboratories)
  • Mylan Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Methotrexate Sodium Sales Value (2021-2032)
  4. 1.2.2 Global Methotrexate Sodium Sales Volume (2021-2032)
  5. 1.2.3 Global Methotrexate Sodium Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Methotrexate Sodium Market Dynamics
  1. 2.1 Methotrexate Sodium Industry Trends
  2. 2.2 Methotrexate Sodium Industry Drivers
  3. 2.3 Methotrexate Sodium Industry Opportunities and Challenges
  4. 2.4 Methotrexate Sodium Industry Restraints
3 Methotrexate Sodium Market by Company
  1. 3.1 Global Methotrexate Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Methotrexate Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Methotrexate Sodium Sales Volume by Company (2021-2026)
  4. 3.4 Global Methotrexate Sodium Average Price by Company (2021-2026)
  5. 3.5 Global Methotrexate Sodium Company Ranking (2024-2026)
  6. 3.6 Global Methotrexate Sodium Company Manufacturing Base and Headquarters
  7. 3.7 Global Methotrexate Sodium Company Product Type and Application
  8. 3.8 Global Methotrexate Sodium Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Methotrexate Sodium Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Methotrexate Sodium Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Methotrexate Sodium Market by Type
  1. 4.1 Methotrexate Sodium Type Introduction
  2. 4.1.1 Methotrexate Sodium Tablet
  3. 4.1.2 Methotrexate Sodium Solution
  4. 4.2 Global Methotrexate Sodium Sales Volume by Type
  5. 4.2.1 Global Methotrexate Sodium Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Methotrexate Sodium Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Methotrexate Sodium Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Methotrexate Sodium Sales Value by Type
  9. 4.3.1 Global Methotrexate Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Methotrexate Sodium Sales Value by Type (2021-2032)
  11. 4.3.3 Global Methotrexate Sodium Sales Value Share by Type (2021-2032)
5 Methotrexate Sodium Market by Application
  1. 5.1 Methotrexate Sodium Application Introduction
  2. 5.1.1 Oral
  3. 5.1.2 Injection
  4. 5.2 Global Methotrexate Sodium Sales Volume by Application
  5. 5.2.1 Global Methotrexate Sodium Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Methotrexate Sodium Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Methotrexate Sodium Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Methotrexate Sodium Sales Value by Application
  9. 5.3.1 Global Methotrexate Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Methotrexate Sodium Sales Value by Application (2021-2032)
  11. 5.3.3 Global Methotrexate Sodium Sales Value Share by Application (2021-2032)
6 Methotrexate Sodium Regional Sales and Value Analysis
  1. 6.1 Global Methotrexate Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Methotrexate Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Methotrexate Sodium Sales by Region: 2021-2026
  4. 6.2.2 Global Methotrexate Sodium Sales by Region (2027-2032)
  5. 6.3 Global Methotrexate Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Methotrexate Sodium Sales Value by Region (2021-2032)
  7. 6.4.1 Global Methotrexate Sodium Sales Value by Region: 2021-2026
  8. 6.4.2 Global Methotrexate Sodium Sales Value by Region (2027-2032)
  9. 6.5 Global Methotrexate Sodium Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Methotrexate Sodium Sales Value (2021-2032)
  12. 6.6.2 North America Methotrexate Sodium Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Methotrexate Sodium Sales Value (2021-2032)
  15. 6.7.2 Europe Methotrexate Sodium Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Methotrexate Sodium Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Methotrexate Sodium Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Methotrexate Sodium Sales Value (2021-2032)
  21. 6.9.2 South America Methotrexate Sodium Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Methotrexate Sodium Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Methotrexate Sodium Sales Value Share by Country, 2025 VS 2032
7 Methotrexate Sodium Country-level Sales and Value Analysis
  1. 7.1 Global Methotrexate Sodium Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Methotrexate Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Methotrexate Sodium Sales by Country (2021-2032)
  4. 7.3.1 Global Methotrexate Sodium Sales by Country (2021-2026)
  5. 7.3.2 Global Methotrexate Sodium Sales by Country (2027-2032)
  6. 7.4 Global Methotrexate Sodium Sales Value by Country (2021-2032)
  7. 7.4.1 Global Methotrexate Sodium Sales Value by Country (2021-2026)
  8. 7.4.2 Global Methotrexate Sodium Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Methotrexate Sodium Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Methotrexate Sodium Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Methotrexate Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 HOSPIRA
  2. 8.1.1 HOSPIRA Company Information
  3. 8.1.2 HOSPIRA Business Overview
  4. 8.1.3 HOSPIRA Methotrexate Sodium Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 HOSPIRA Methotrexate Sodium Product Portfolio
  6. 8.1.5 HOSPIRA Recent Developments
  7. 8.2 Qualitest(DAVA Pharmaceuticals)
  8. 8.2.1 Qualitest(DAVA Pharmaceuticals) Company Information
  9. 8.2.2 Qualitest(DAVA Pharmaceuticals) Business Overview
  10. 8.2.3 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Product Portfolio
  12. 8.2.5 Qualitest(DAVA Pharmaceuticals) Recent Developments
  13. 8.3 Roxane Laboratories Inc.
  14. 8.3.1 Roxane Laboratories Inc. Company Information
  15. 8.3.2 Roxane Laboratories Inc. Business Overview
  16. 8.3.3 Roxane Laboratories Inc. Methotrexate Sodium Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Roxane Laboratories Inc. Methotrexate Sodium Product Portfolio
  18. 8.3.5 Roxane Laboratories Inc. Recent Developments
  19. 8.4 STADA Pharmaceuticals, Inc
  20. 8.4.1 STADA Pharmaceuticals, Inc Company Information
  21. 8.4.2 STADA Pharmaceuticals, Inc Business Overview
  22. 8.4.3 STADA Pharmaceuticals, Inc Methotrexate Sodium Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 STADA Pharmaceuticals, Inc Methotrexate Sodium Product Portfolio
  24. 8.4.5 STADA Pharmaceuticals, Inc Recent Developments
  25. 8.5 Teva USA(Barr Laboratories)
  26. 8.5.1 Teva USA(Barr Laboratories) Company Information
  27. 8.5.2 Teva USA(Barr Laboratories) Business Overview
  28. 8.5.3 Teva USA(Barr Laboratories) Methotrexate Sodium Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teva USA(Barr Laboratories) Methotrexate Sodium Product Portfolio
  30. 8.5.5 Teva USA(Barr Laboratories) Recent Developments
  31. 8.6 Mylan Pharmaceuticals Inc.
  32. 8.6.1 Mylan Pharmaceuticals Inc. Company Information
  33. 8.6.2 Mylan Pharmaceuticals Inc. Business Overview
  34. 8.6.3 Mylan Pharmaceuticals Inc. Methotrexate Sodium Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Pharmaceuticals Inc. Methotrexate Sodium Product Portfolio
  36. 8.6.5 Mylan Pharmaceuticals Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Methotrexate Sodium Value Chain Analysis
  2. 9.1.1 Methotrexate Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Methotrexate Sodium Sales Mode & Process
  6. 9.2 Methotrexate Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Methotrexate Sodium Distributors
  9. 9.2.3 Methotrexate Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst